再鼎医药获摩根大通增持约192.01万股 每股作价约13.34港元

Summary of Key Points Core Viewpoint - JPMorgan Chase has increased its stake in Zai Lab Limited (09688) by acquiring 1,920,096 shares at a price of HKD 13.3426 per share, totaling approximately HKD 25.6191 million, resulting in a new holding of about 56,470,300 shares, which represents a 5.04% ownership stake [1][3]. Group 1 - JPMorgan Chase's acquisition of shares indicates a strategic investment in Zai Lab Limited [1][3]. - The total amount spent on the share purchase was approximately HKD 25.6191 million [1][3]. - Following the purchase, JPMorgan's total shareholding in Zai Lab is now approximately 56,470,300 shares [1][3].